Inversion deals should be welcomed, says PwC

Foreign companies that take over UK companies for tax reasons should be welcomed, according to the chairman of PwC UK.

The recent attempt by US drug maker Pfizer to buy its UK-Swedish rival, Astra Zeneca, was partly based on the tax it would save by domiciling its company in the UK where the corporate tax rate is lower than the US.


» Register now

The full article is available to registered AccountingWEB members only. To read the rest of this article you’ll need to login or register.

Registration is FREE and allows you to view all content, ask questions, comment and much more.